Savara, Inc. (SVRA)
4.96
-0.20
(-3.88%)
USD |
NASDAQ |
Mar 20, 16:00
4.98
+0.02
(+0.40%)
After-Hours: 20:00
Savara Total Assets (Quarterly) : 253.44M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 777.78M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| BioMarin Pharmaceutical, Inc. | 7.594B |
| Imunon, Inc. | 8.988M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 50.30M |
| Shareholders Equity (Quarterly) | 203.13M |
| Debt to Equity Ratio | 0.1473 |
| Current Ratio | 11.85 |
| Net Debt Paydown Yield | -0.05% |